RCRuth Cassidy

Ruth Cassidy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ruth Cassidy has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Machine Learning to Identify Point-of-Care Ultrasound and Evaluate Standardized Documentation: Retrospective Operational Cohort Study

    by Kevin Nguyen, Zewen Wu, Chu-An Tsai, John Vandervest, D’ANna Lammers, Ruth Cassidy, Zachary Murphy, Balaji Pandian, Maya M Hammoud, Jennifer Collin, et al.

    Background: Point-of-care ultrasound (POCUS) is integral to obstetrics and gynecology (OBGYN), offering bedside diagnostic and therapeutic advantages. Despite its widespread adoption, accurate documentation and billing remain challenging due to inconsistent workflows, variable free-text note quality, and inefficiencies within electronic health record (EHR) systems. These barriers often result in missed procedural charges and hinder operational, educational, and reimbursement efforts. Objective: This study leveraged machine learning (ML) to automatically identify POCUS procedures within clinical notes and assessed the effect of implementing standardized procedure documentation (ProcDoc) templates on billing capture accuracy and efficiency. Methods: We conducted a multipart retrospective cohort study at a large academic medical center using EHRs from January 2018 to August 2024 across 11 OBGYN clinic sites. ML models (LightGBM [light gradient boosting machine] and BioClinBERT [biomedical and clinical bidirectional encoder representations from transformers]) were trained on clinical encounter notes to classify POCUS procedures and validated against Current Procedural Terminology (CPT) manual code assignments. In February 2023, a standardized ProcDoc smart form was introduced to streamline POCUS documentation and automatically trigger CPT billing codes. Preintervention and postintervention periods were compared using ML metrics and manual billing audits. Outcomes included model accuracy, recall, precision, adoption rates, improvement in billing recapture, and usage of ProcDoc templates. Results: A total of 559,029 encounters from 109,776 unique patients were analyzed. The BioClinBERT model (accuracy 0.97; F 1 -score 0.55-0.63) demonstrated a robust ability to identify documented and missed procedures in free-text clinical notes. ProcDoc adoption reached 75.1% within 12 months, supported by comprehensive staff education. Billing recapture—the proportion of charges missed by providers but later identified—dropped from 10.0% preintervention to 2.4% postintervention, primarily arising from the shift toward auto-capturing documentation (odds ratio 0.22, 95% CI 0.17‐0.30; P <.001), with overall POCUS billing slightly increased (+0.6%). Most postintervention CPT codes (1812/2404, 75.4%) originated from ProcDoc templates, confirming improved workflow efficiency and reduced manual audit burden. Model analysis and billing metrics demonstrated that improvements were associated with workflow changes and not an increase in procedure frequency. Conclusions: ML modeling proved effective for extracting POCUS procedures from clinical documentation and serving as an evaluation tool for workflow interventions. Standardized documentation with ProcDoc significantly enhanced charge capture accuracy and reduced dependence on manual chart reviews and billing reconciliation. This approach highlights the use of ML as a retrospective auditing and evaluation tool for assessing clinical workflow interventions. Broader application of similar strategies could address documentation inefficiencies and promote sustainability across health care settings.

  • Open Access

    Weight‐Based Standardized Sugammadex Dosing in Pediatrics: A Quality Improvement Initiative to Improve Compliance with Dosing Guidelines and Reduce Waste and Cost

    by Sydney E. S. Brown, Michael Meyer, Andrea Meyer, Ruth Cassidy, Xinyi Zhao, Deborah Wagner, Laura Wetzel, Douglas A. Colquhoun

    Study Objective. Sugammadex is a widely used neuromuscular blockade reversal agent. Cost concerns limit use in pediatric patients for, whom recommended doses are often far less than vial quantities. Therefore, we undertook a quality improvement initiative at a pediatric hospital in which sugammadex vials were fractionated. We hypothesized we would see a decrease in administered dose and waste and improved adherence with dosing guidelines. Methods. Sugammadex vials were fractionated into 25, 50, or 100 mg aliquots, which would be distributed to anesthesia staff by pharmacy staff in approximate 2 mg/kg of actual body weight doses (±10%). We analyzed changes in sugammadex waste and dosing practices 1/1/2019 to 3/15/2023 pre/postintervention (4/1/2021). We gauged dose appropriateness using last train of four (TOF) prior to sugammadex administration. Results. 7,889 patients 2–17 years (4,771 with documented TOF), ASA 1–4 receiving general anesthesia with a steroidal NMB medication and sugammadex reversal. Pre‐ and postintervention mean doses were 2.5 mg/kg (SD: 1.2) and 2.4 mg/kg (SD: 0.96), respectively. A smaller proportion of cases received standard 2 or 4 mg/kg doses (pre: 77.6 vs. post: 66.7%). Mean waste per case declined from 4.2 mg/kg (SD: 4.1) to 0.22 mg/kg (SD: 0.38). Among cases with 0 or 1 measured twitches on TOF that should receive at least 4 mg/kg, fewer received at least 3.6 mg/kg (post: 56.7% vs. pre: 66.8%), and a greater proportion received less than 2.2 mg/kg (post: 27.4% vs. pre: 20.7%). Among cases that should have received at least 2 mg/kg by TOF, the proportion of patients receiving more than 3.6 mg/kg declined from 9.5% to 5.2%. Discussion. Fractionating sugammadex vials was associated with decreases in waste, but not dose, and significant underdosing was more likely to occur. While vial fractionation could enable increased access to sugammadex and other costly medications, it may introduce unintended consequences.

  • Labor epidural analgesia and the risk of postpartum depression: A meta-analysis of observational studies

    by Joanna A Kountanis, Christie Vahabzadeh, Samuel Bauer, Maria Muzik, Ruth Cassidy, Casey Aman, Mark MacEachern, Melissa E Bauer


  • Sacral anatomical interspace landmark for lumbar puncture in pregnancy

    by Carlo Pancaro, Baskar Rajala, Christie Vahabzadeh, Ruth Cassidy, Thomas T. Klumpner, Joanna A. Kountanis, Madeline McCabe, Dana Rector, Casey Aman, Keerthana Sankar, et al.

    Objective To determine whether the sacral anatomical interspace landmark (SAIL) technique is more accurate than the classic intercristal line (ICL) technique in pregnant patients and to assess the percentage of clinical determinations above the third lumbar vertebra. Methods In this prospective, randomized, open-label trial, there were 110 singleton pregnant patients with gestational age greater than 37 weeks included. Selection procedure was a convenience sample of pregnant patients who presented for office visits or vaginal or cesarean delivery between March 15 and July 31, 2018, at a single-center obstetric tertiary care university hospital. Both techniques were evaluated by 2 physicians independently assessing each method. Before data collection, we hypothesized that the SAIL technique would be more accurate than the ICL technique in determining the L4-L5 interspace, and that the SAIL technique would produce more estimations below the third lumbar vertebra than the ICL technique. Therefore, the primary outcome was accuracy in identifying the L4-L5 lumbar interspace with SAIL vs ICL. The secondary outcome was difference in clinical assessments above the third lumbar vertebra. Both outcomes were measured via ultrasonography. Results Patients were 31 ± 5 years of age (mean ± SD) and had body mass index of 31.8 ± 5.7 kg/m2 and gestational age of 38.8 ± 1.1 weeks. A total of 110 patients were analyzed. SAIL correctly identified the L4-L5 interspace 49% of the time vs 8% using ICL (p < 0.0001). Estimations above L3 were 1% for SAIL vs 31% for ICL (p < 0.0001). Conclusions Our study shows improved accuracy in identifying intervertebral space using the SAIL technique; this may prevent direct mechanical trauma to the conus medullaris when lumbar punctures are performed in pregnancy. Clinicaltrials.gov identifier NCT03433612.


  • Metabolic Parameters, Weight Loss, and Comorbidities 4 Years After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy

    by Corey J. Lager, Nazanene H. Esfandiari, Yingying Luo, Angela R. Subauste, Andrew T. Kraftson, Morton B. Brown, Oliver A. Varban, Rasimcan Meral, Ruth B. Cassidy, Catherine K. Nay, et al.

    Background Sleeve gastrectomy (LSG) is now the predominant bariatric surgery performed, yet there is limited long-term data comparing important outcomes between LSG and Roux-en-Y gastric bypass (RYGB). This study compares weight loss and impact on comorbidities of the two procedures. Methods We retrospectively evaluated weight, blood pressure, hemoglobin A1c, cholesterol, and medication use for hypertension, diabetes, and hyperlipidemia at 1–4 years post-operatively in 380 patients who underwent RYGB and 334 patients who underwent LSG at the University of Michigan from January 2008 to November 2013. Follow-up rates from 714 patients initially were 657 (92%), 556 (78%), 507 (71%), and 498 (70%) at 1–4 years post-operatively. Results Baseline characteristics were similar except for higher weight and BMI in LSG. There was greater weight loss with RYGB vs. LSG at all points. Hemoglobin A1c and total cholesterol improved more in RYGB vs. LSG at 4 years. There was greater remission of hypertension and discontinuation of all medications for hypertension and diabetes with RYGB at 4 years. Conclusions Weight loss, reduction in medications for hypertension and diabetes, improvements in markers of diabetes and hyperlipidemia, and remission rates of hypertension were superior with RYGB vs. LSG 4 years post-operatively. Choice of bariatric procedures should be tailored to surgical risk, comorbidities, and weight loss goals.


  • Open Access

    Milestone Weight Loss Goals (Weight Normalization and Remission of Obesity) after Gastric Bypass Surgery: Long-Term Results from the University of Michigan

    by Corey J. Lager, Nazanene H. Esfandiari, Angela R. Subauste, Andrew T. Kraftson, Morton B. Brown, Ruth B. Cassidy, Darlene Bellers, Amy L. Lockwood, Oliver A. Varban, Elif A. Oral

    Background Rates of weight normalization and obesity remission after Roux-en-Y gastric bypass (GB) are unknown. This study evaluated weight loss, rates of achieving body mass index (BMI) 2, recidivism, and predictors of success following GB. Methods We retrospectively studied weight and BMI at baseline, 2 and 6 months, and annually at 1–7 years in 219 patients undergoing GB at the University of Michigan from January 2008 to November 2010. Results Follow-up was excellent for a population traditionally associated with high attrition rates with data availability of 157/219, 145/219, 144/219, 134/219, 123/219, 82/161, and 29/64 patients at 1–7 years, respectively. Mean baseline BMI was 47.0 kg/m2. Weight normalization (BMI 2) occurred in 2.3–6.8% of patients. More importantly, 47% of patients achieved remission of obesity (BMI 2) at some time point and 24% (52/219) at the last observed time point. BMI 2 was associated with a lower initial BMI and follow-up for more than 2 years. Conclusions Rates of weight normalization are low after GB; however, a large number of patients achieved BMI 2. While the percent total weight loss and excess weight loss are both quite high in the entire cohort and this is likely associated with significant health benefits, our results still underscore the need to address obesity with intensive clinical attention earlier in its course.